scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1021960914 |
P356 | DOI | 10.1186/1475-2875-6-25 |
P932 | PMC publication ID | 1820788 |
P698 | PubMed publication ID | 17328806 |
P5875 | ResearchGate publication ID | 6477397 |
P50 | author | Piero Olliaro | Q72250873 |
Lyda Osorio | Q37366860 | ||
P2093 | author name string | Walter R J Taylor | |
Iveth Gonzalez | |||
P2860 | cites work | Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia | Q25257833 |
Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug? | Q34121270 | ||
Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial | Q34413590 | ||
Pharmacovigilance of antimalarial treatment in Africa: is it possible? | Q34872414 | ||
Artemisinins | Q35521094 | ||
Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria | Q37121012 | ||
Antimalarial drugs in pregnancy: a review. | Q37239309 | ||
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study | Q39309831 | ||
The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment | Q39474503 | ||
The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria | Q40573522 | ||
Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia. | Q41922288 | ||
Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin | Q41942911 | ||
The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units | Q41944054 | ||
Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | Q44167789 | ||
Efficacy of amodiaquine and sulfadoxine/pyrimethamine in the treatment of malaria not complicated by Plasmodium falciparum in Nariño, Colombia, 1999-2002 | Q44404041 | ||
Artesunate combinations for treatment of malaria: meta-analysis | Q44728450 | ||
Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia | Q46654529 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | Colombia | Q739 |
malaria | Q12156 | ||
Plasmodium falciparum | Q311383 | ||
artemisinin | Q426921 | ||
Plasmodium falciparum malaria | Q18554672 | ||
P304 | page(s) | 25 | |
P577 | publication date | 2007-02-28 | |
P1433 | published in | Malaria Journal | Q15749954 |
P1476 | title | Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia | |
P478 | volume | 6 |
Q37010425 | A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya |
Q36450015 | Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling |
Q40261794 | Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial |
Q56641839 | Artesunate Plus Amodiaquine Combination Therapy: Reviewing the Evidence |
Q61455637 | Assessment of adverse drug reactions in the home management of malaria cases of children under 5 years using artemisinin-based combination therapy in Mfou health district, Center region of Cameroon |
Q27014789 | Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis |
Q33686633 | Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study |
Q37350167 | Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis |
Q35183422 | Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance |
Q41911890 | K13-propeller Alleles, Mdr1 Polymorphism, and Drug Effectiveness at Day 3 after Artemether-lumefantrine Treatment for Plasmodium falciparum Malaria in Colombia, 2014-2015. |
Q34538134 | Long term persistence of clonal malaria parasite Plasmodium falciparum lineages in the Colombian Pacific region |
Q26997119 | Malaria-related anaemia: a Latin American perspective |
Q35189138 | Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa |
Q99591398 | Natural Products: A Potential Source of Malaria Transmission Blocking Drugs? |
Q30936416 | The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data |
Q37144195 | The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum |
Q36612831 | Variations in antimalarial components of Artemisia annua Linn from three regions of Uganda |